IV Correction of Hypocalcemia

Agent Selection

Calcium chloride should be used preferentially over calcium gluconate due to its higher elemental calcium content, with 10 mL of 10% calcium chloride containing 270 mg elemental calcium, and its advantage in hepatic dysfunction as it does not require hepatic metabolism for release of ionized calcium 1, 2
The American College of Critical Care recommends calcium chloride for central line administration due to its higher potency, making it more efficient 1, 2
However, calcium gluconate is preferred for peripheral IV administration due to significantly less tissue irritation and lower risk of severe skin/soft tissue injury from extravasation 3

In cases of moderate to severe hypocalcemia, ionized Ca²⁺ <0.8 mmol/L is associated with cardiac dysrhythmias and requires urgent correction, according to the Critical Care society 1, 2
For transfusion-associated hypocalcemia, correction threshold is ionized Ca²⁺ <0.9 mmol/L or total corrected calcium ≤7.5 mg/dL, and each unit of pRBC or FFP contains ~3 g citrate that chelates serum Ca²⁺, as stated by the Critical Care society 1, 2

For calcium channel blocker toxicity, 0.6 mL/kg of 10% calcium gluconate over 5-10 minutes, followed by 0.3 mEq/kg/hour, is recommended by Praxis Medical Insights 3
In cases of CCB poisoning with hemodynamic instability, 30-60 mL (3-6 g) of 10% calcium gluconate every 10-20 minutes, or continuous infusion at 0.6-1.2 mL/kg/hour, is recommended by Praxis Medical Insights 3

Central venous catheter is strongly preferred to avoid calcinosis cutis and tissue necrosis, and secure IV line is mandatory before administration, as recommended by Praxis Medical Insights 3
Extravasation risk is high with peripheral administration of calcium chloride, and calcium gluconate should be used peripherally if central access is unavailable, according to Praxis Medical Insights 3
The administration of nephrotoxic chemotherapy (platinum salts, certain antibiotics, NSAIDs) should be avoided on the same day as IV bisphosphonates to reduce renal toxicity risk, as recommended by the Annals of Oncology society 4

The most critical error is using calcium gluconate when calcium chloride would be more appropriate in acute, severe hypocalcemia with central access available, due to the three-fold difference in elemental calcium content, as stated by the Critical Care society 1, 2